Bringing you the latest cutting-edge research and commentary in bioscience.

Cell & Gene Therapy Insights

Cell & Gene Therapy Insights

Interview
Spotlight Article

Drawing parallels and cross-pollinating ideas between viral vector and vaccine fields

Viral vector bioprocessing & analytics: today’s key tools and innovation requirements to meet future demand

AMINE KAMEN is Professor of Bioengineering at McGill University, and Canada Research Chair in Bioprocessing of Viral Vaccines. He is Researcher Emeritus of the National Research Council of Canada (NRC) where he was employed until the end of 2013, as Head of the Process Development section of the Human Health Therapeutics Portfolio. At NRC, he established one of North America’s largest and most advanced governmental centers for animal cell culture addressing process development and scale up of biologics. Along with his team he also licensed multiple technology platforms for efficient manufacturing of recombinant proteins, viral vectors, and vaccines, and led technology transfer to manufacturing sites for clinical evaluation and commercialization.

DOI: 10.18609/cgti.2020.045
Citation: Cell & Gene Therapy Insights 2020; 6(3), 359–365
Open access
This content is restricted to registered users. Click here to Register or Login here.
Twitter IconVisit Our Blog